Fox Jr, 1975 - Google Patents
83 Hypertonic Balanced Sodium Solution in Bum ShockFox Jr, 1975
- Document ID
- 2952369338054516236
- Author
- Fox Jr C
- Publication year
- Publication venue
- 116 Anaesthesiologie und Intensivmedizin Anaesthesiology
External Links
Snippet
The study was designed to ascertain the most effective sodium solution for resuscitation after potentially fatal thermal injury. Solutions containing from 75 to 300 mEqJL of sodium were adrninisteted in various doses to mice subjected to a standardized scald. Their effectiveness …
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Na] 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/893—Liver disorder
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0270317A3 (en) | Pharmaceutical compositions for the treatment of diseases caused by viruses | |
| US4886670A (en) | Anti-viral compositions | |
| IE821258L (en) | Anti-herpes medicaments | |
| Fox Jr | 83 Hypertonic Balanced Sodium Solution in Bum Shock | |
| JPS5470428A (en) | Carcinostatic agent | |
| JPS5630917A (en) | Preventive and remedy for hepatitis | |
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| IE55973B1 (en) | The use of undecylenic acid for the manufacture of a composition for the treatment of herpes labialis | |
| IE790302L (en) | Treatment of diptera | |
| JPS5791922A (en) | Antiviral agent of external use | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| Lauber et al. | Toxicity of the mucigogue, eugenol, administered by stomach tube to dogs | |
| JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
| DE3365954D1 (en) | The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles | |
| JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
| JPS57108014A (en) | Antithrombotic agent | |
| JPS55149213A (en) | Remedy of dna for viral disease | |
| JPS5686114A (en) | Pharmaceutical composition for suppository | |
| JPS52130906A (en) | Stable solution of uracil derivative | |
| JPS57108017A (en) | Antithrombotic agent | |
| JPS57108016A (en) | Antithrombotic agent | |
| JPS5742620A (en) | Novel antiulcer agent | |
| JPS5634625A (en) | Antitumorigenic agent | |
| ELSKAMP | Toxic properties of CN and CS(alpha-chloroacetophenone and o-chlorobenzylidenemalononitrile) | |
| Krivorutchenko et al. | The effect of fetal calf serum on the anti-HIV properties of miramistin |